| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Communicable Diseases; Infection; Urinary Tract Infections | Phase 4 | ClinicalTrials |
| Enuresis; Nocturnal Enuresis; Urinary Incontinence | Phase 2 | ClinicalTrials |
| Brain Diseases; Hepatic Encephalopathy | Phase 4 | ClinicalTrials |
| Attention Deficit Disorder with Hyperactivity; Hyperkinesis | Phase 2 | ClinicalTrials |
| Hyperalgesia | Phase 1 | ClinicalTrials |
| Raynaud Disease | Phase 3 | ClinicalTrials |
| Bronchiolitis; Bronchiolitis Obliterans; Lung Diseases, Obstructive | Phase 2 | ClinicalTrials |
| Diarrhea | Phase 3 | ClinicalTrials |
| Migraine Disorders | Phase 2 | ClinicalTrials |
| Nausea; Vomiting | Phase 2 | ClinicalTrials |
| Gastroesophageal Reflux | Phase 2 | ClinicalTrials |
CONTENTS